Accéder au contenu
Merck

New synthetic thiocolchicine derivatives as lowtoxic anticancer agents.

Archiv der Pharmazie (2005-12-15)
Sun-Hee Lee, Sun-Kyoung Park, Jeong-Mi Kim, Myung-Hwa Kim, Kwang-Hee Kim, Kwang-Woo Chun, Kyung-Hea Cho, Ji-Youn Youn, Sung Keon Namgoong
RÉSUMÉ

New thiocolchicine derivatives (1-8) were designed as less toxic anticancer agents possessing the power full anticancer activity of colchicine. The synthesis and biological evaluation of these compounds were described. As a preliminary result of biological in vitro investigation, compounds 1, 6, and 7 showed lower toxicities than that of colchicine in combination with potent anticancer activities.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Thiocolchicine, ≥97% (HPLC)